TY - CHAP PY - 2013 DA - 2013// TI - Bipolar and related disorders BT - Diagnostic and statistical manual of mental disorders UR - https://doi.org/10.1176/appi.books.9780890425596 DO - 10.1176/appi.books.9780890425596 ID - ref1 ER - TY - JOUR AU - Merikangas, K. R. AU - Jin, R. AU - He, J. P. AU - Kessler, R. C. AU - Lee, S. AU - Sampson, N. A. AU - Viana, M. C. AU - Andrade, L. H. AU - Hu, C. AU - Karam, E. G. PY - 2011 DA - 2011// TI - Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative JO - Arch Gen Psychiatry VL - 68 UR - https://doi.org/10.1001/archgenpsychiatry.2011.12 DO - 10.1001/archgenpsychiatry.2011.12 ID - Merikangas2011 ER - TY - JOUR AU - Goodwin, G. M. AU - Haddad, P. M. AU - Ferrier, I. N. AU - Aronson, J. K. AU - Barnes, T. AU - Cipriani, A. AU - Coghill, D. R. AU - Fazel, S. AU - Geddes, J. R. AU - Grunze, H. PY - 2016 DA - 2016// TI - Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology JO - J Psychopharmacol VL - 30 UR - https://doi.org/10.1177/0269881116636545 DO - 10.1177/0269881116636545 ID - Goodwin2016 ER - TY - JOUR AU - Grunze, H. AU - Vieta, E. AU - Goodwin, G. M. AU - Bowden, C. AU - Licht, R. W. AU - Möller, H. J. AU - Kasper, S. PY - 2010 DA - 2010// TI - WFSBP task force on treatment guidelines for bipolar disorders. The world Federation of Societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression JO - World J Biol Psychiatry. VL - 11 UR - https://doi.org/10.3109/15622970903555881 DO - 10.3109/15622970903555881 ID - Grunze2010 ER - TY - JOUR AU - Kanba, S. AU - Kato, T. AU - Terao, T. AU - Yamada, K. PY - 2013 DA - 2013// TI - Committee for Treatment Guidelines of mood disorders. JSoMD guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012 JO - Psychiatry Clin Neurosci VL - 67 UR - https://doi.org/10.1111/pcn.12060 DO - 10.1111/pcn.12060 ID - Kanba2013 ER - TY - JOUR AU - Yatham, L. N. AU - Kennedy, S. H. AU - Parikh, S. V. AU - Schaffer, A. AU - Beaulieu, S. AU - Alda, M. AU - O'Donovan, C. AU - Macqueen, G. AU - McIntyre, R. S. AU - Sharma, V. PY - 2013 DA - 2013// TI - Canadian network for mood and anxiety treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013 JO - Bipolar Disord VL - 15 UR - https://doi.org/10.1111/bdi.12025 DO - 10.1111/bdi.12025 ID - Yatham2013 ER - TY - JOUR AU - Calabrese, J. R. AU - Keck, P. E. AU - Macfadden, W. AU - Minkwitz, M. AU - Ketter, T. A. AU - Weisler, R. H. AU - Cutler, A. J. AU - McCoy, R. AU - Wilson, E. AU - Mullen, J. PY - 2005 DA - 2005// TI - A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression JO - Am J Psychiatry VL - 162 UR - https://doi.org/10.1176/appi.ajp.162.7.1351 DO - 10.1176/appi.ajp.162.7.1351 ID - Calabrese2005 ER - TY - JOUR AU - Thase, M. E. AU - Macfadden, W. AU - Weisler, R. H. AU - Chang, W. AU - Paulsson, B. AU - Khan, A. AU - Calabrese, J. R. PY - 2006 DA - 2006// TI - Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study) JO - J Clin Psychopharmacol VL - 26 UR - https://doi.org/10.1097/01.jcp.0000248603.76231.b7 DO - 10.1097/01.jcp.0000248603.76231.b7 ID - Thase2006 ER - TY - JOUR AU - Suppes, T. AU - Datto, C. AU - Minkwitz, M. AU - Nordenhem, A. AU - Walker, C. AU - Darko, D. PY - 2010 DA - 2010// TI - Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression JO - J Affect Disord VL - 121 UR - https://doi.org/10.1016/j.jad.2009.10.007 DO - 10.1016/j.jad.2009.10.007 ID - Suppes2010 ER - TY - JOUR AU - Murasaki, M. AU - Koyama, T. AU - Kanba, S. AU - Takeuchi, M. AU - Shimizu, Y. AU - Arita, E. AU - Kuroishi, K. AU - Takeuchi, M. AU - Kamei, S. PY - 2018 DA - 2018// TI - Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression JO - Psychopharmacology. VL - 235 UR - https://doi.org/10.1007/s00213-018-4977-6 DO - 10.1007/s00213-018-4977-6 ID - Murasaki2018 ER - TY - JOUR AU - Judd, L. L. AU - Akiskal, H. S. AU - Schettler, P. J. AU - Coryell, W. AU - Endicott, J. AU - Maser, J. D. AU - Solomon, D. A. AU - Leon, A. C. AU - Keller, M. B. PY - 2003 DA - 2003// TI - A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder JO - Arch Gen Psychiatry VL - 60 UR - https://doi.org/10.1001/archpsyc.60.3.261 DO - 10.1001/archpsyc.60.3.261 ID - Judd2003 ER - TY - JOUR AU - Judd, L. L. AU - Akiskal, H. S. AU - Schettler, P. J. AU - Endicott, J. AU - Maser, J. AU - Solomon, D. A. AU - Leon, A. C. AU - Rice, J. A. AU - Keller, M. B. PY - 2002 DA - 2002// TI - The long-term natural history of the weekly symptomatic status of bipolar I disorder JO - Arch Gen Psychiatry VL - 59 UR - https://doi.org/10.1001/archpsyc.59.6.530 DO - 10.1001/archpsyc.59.6.530 ID - Judd2002 ER - TY - JOUR AU - Young, A. H. AU - McElroy, S. L. AU - Olausson, B. AU - Paulsson, B. AU - Embolden, I. PY - 2014 DA - 2014// TI - Embolden II investigators. A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder JO - World J Biol Psychiatry VL - 15 UR - https://doi.org/10.3109/15622975.2012.665177 DO - 10.3109/15622975.2012.665177 ID - Young2014 ER - TY - STD TI - American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: American Psychiatric Association Publishing; 2000. ID - ref14 ER - TY - JOUR AU - Spearing, M. K. AU - Post, R. M. AU - Leverich, G. S. AU - Brandt, D. AU - Nolen, W. PY - 1997 DA - 1997// TI - Modification of the clinical global impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP JO - Psychiatry Res VL - 73 UR - https://doi.org/10.1016/S0165-1781(97)00123-6 DO - 10.1016/S0165-1781(97)00123-6 ID - Spearing1997 ER - TY - STD TI - International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonised tripartite guideline: the extent of population exposure to assess clinical safety for drugs intended for long-term treatment of non-life-threatening conditions—E1. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E1/Step4/E1_Guideline.pdf (Accessed June 19, 2018). UR - http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E1/Step4/E1_Guideline.pdf ID - ref16 ER - TY - JOUR AU - McElroy, S. L. AU - Weisler, R. H. AU - Chang, W. AU - Olausson, B. AU - Paulsson, B. AU - Brecher, M. AU - Agambaram, V. AU - Merideth, C. AU - Nordenhem, A. AU - Young, A. H. PY - 2010 DA - 2010// TI - A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II) JO - J Clin Psychiatry. VL - 71 UR - https://doi.org/10.4088/JCP.08m04942gre DO - 10.4088/JCP.08m04942gre ID - McElroy2010 ER - TY - JOUR AU - Young, A. H. AU - McElroy, S. L. AU - Bauer, M. AU - Philips, N. AU - Chang, W. AU - Olausson, B. AU - Paulsson, B. AU - Brecher, M. PY - 2010 DA - 2010// TI - A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I) JO - J Clin Psychiatry VL - 71 UR - https://doi.org/10.4088/JCP.08m04995gre DO - 10.4088/JCP.08m04995gre ID - Young2010 ER - TY - STD TI - Nashed MG, Restivo MR, Taylor VH. Olanzapine-induced weight gain in patients with Bipolar I Disorder: A meta-Analysis. Prim Care Companion CNS Disord. 2011;13(6). https://doi.org/10.4088/PCC.11r01174. ID - ref19 ER - TY - JOUR AU - Hert, M. AU - Yu, W. AU - Detraux, J. AU - Sweers, K. AU - Winkel, R. AU - Correll, C. U. PY - 2012 DA - 2012// TI - Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis JO - CNS Drugs VL - 26 UR - https://doi.org/10.2165/11634500-000000000-00000 DO - 10.2165/11634500-000000000-00000 ID - Hert2012 ER - TY - JOUR AU - Correll, C. U. AU - Detraux, J. AU - Lepeleire, J. AU - Hert, M. PY - 2015 DA - 2015// TI - Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder JO - World Psychiatry VL - 14 UR - https://doi.org/10.1002/wps.20204 DO - 10.1002/wps.20204 ID - Correll2015 ER - TY - JOUR AU - McLaren, K. D. AU - Marangell, L. B. PY - 2004 DA - 2004// TI - Special considerations in the treatment of patients with bipolar disorder and medical co-morbidities JO - Ann Gen Hosp Psychiatry VL - 3 UR - https://doi.org/10.1186/1475-2832-3-7 DO - 10.1186/1475-2832-3-7 ID - McLaren2004 ER - TY - JOUR AU - Torre, D. AU - Falorni, A. PY - 2007 DA - 2007// TI - Pharmacological causes of hyperprolactinemia JO - Ther Clin Risk Manag VL - 3 ID - Torre2007 ER - TY - JOUR AU - Kapur, S. AU - Zipursky, R. AU - Jones, C. AU - Shammi, C. S. AU - Remington, G. AU - Seeman, P. PY - 2000 DA - 2000// TI - A positron emission tomography study of quetiapine in schizophrenia JO - Arch Gen Psychiatry VL - 57 UR - https://doi.org/10.1001/archpsyc.57.6.553 DO - 10.1001/archpsyc.57.6.553 ID - Kapur2000 ER - TY - JOUR AU - Atmaca, M. AU - Kuloglu, M. AU - Tezcan, E. AU - Canatan, H. AU - Gecici, O. PY - 2002 DA - 2002// TI - Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidol JO - Arch Med Res VL - 33 UR - https://doi.org/10.1016/S0188-4409(02)00403-4 DO - 10.1016/S0188-4409(02)00403-4 ID - Atmaca2002 ER - TY - JOUR AU - Gao, K. AU - Kemp, D. E. AU - Ganocy, S. J. AU - Gajwani, P. AU - Xia, G. AU - Calabrese, J. R. PY - 2008 DA - 2008// TI - Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia JO - J Clin Psychopharmacol VL - 28 UR - https://doi.org/10.1097/JCP.0b013e318166c4d5 DO - 10.1097/JCP.0b013e318166c4d5 ID - Gao2008 ER - TY - JOUR AU - Correll, C. U. AU - Leucht, S. AU - Kane, J. M. PY - 2004 DA - 2004// TI - Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies JO - Am J Psychiatry VL - 161 UR - https://doi.org/10.1176/appi.ajp.161.3.414 DO - 10.1176/appi.ajp.161.3.414 ID - Correll2004 ER - TY - JOUR AU - Viktorin, A. AU - Lichtenstein, P. AU - Thase, M. E. AU - Larsson, H. AU - Lundholm, C. AU - Magnusson, P. K. AU - Landen, M. PY - 2014 DA - 2014// TI - The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer JO - Am J Psychiatry VL - 171 UR - https://doi.org/10.1176/appi.ajp.2014.13111501 DO - 10.1176/appi.ajp.2014.13111501 ID - Viktorin2014 ER -